Loading...
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
Ovarian clear cell carcinomas (OCCC) constitute a rare subtype of epithelial ovarian cancer, lacking efficient treatment options. Based on previous studies, we assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G,...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7546754/ https://ncbi.nlm.nih.gov/pubmed/33088426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27747 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|